Effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) on the clinical outcomes of patients with diabetic atrial fibrillation
In our study, SGLT-2i treatment was associated with a significant reduction in all-cause mortality and major bleeding in diabetic AF patients. Our study provides evidence of the clinical benefit of SGLT-2i in AF patients.
Authors
- Onur Altınkaya (ORCID: https://orcid.org/0000-0002-2178-6140)
- Sidar Şiyar Aydın (ORCID: https://orcid.org/0000-0002-8204-1505)
- Oğuzhan Birdal (ORCID: https://orcid.org/0000-0002-0667-2516)
- Emrah Aksakal (ORCID: https://orcid.org/0000-0001-5765-4281)
- Selim Aydemir (ORCID: https://orcid.org/0000-0001-6654-2521)
- Murat Özmen (ORCID: https://orcid.org/0000-0002-6237-1398)
Institutions
- Erzurum Regional Training and Research Hospital (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Atatürk University (TR)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1186/s12872-024-04454-1
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72